Clinical trial

A Study of ARQ 197 in Combination With Erlotinib

NCT01069757

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-02-01

PhasePHASE1

Study timeline

Study start (unknown)2010-02-01Date precision: month

Registry last updated2017-03-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small-cell Lung Cancerunresolved

Interventions

ARQ 197 and ErlotinibDRUG

Sponsors & collaborators

Kyowa Kirin Co., Ltd.lead sponsor

Mapped research locations

OsakaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01069757 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.